Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
4,214
Total Claims
$913K
Drug Cost
321
Beneficiaries
$2,845
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+3%
Opioid rate vs peers
2.7% vs 2.6% avg
+166%
Cost per patient vs peers
$2,845 vs $1,068 avg
+134%
Brand preference vs peers
21.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.7%
Opioid Rate
112
Opioid Claims
$5,415
Opioid Cost
18.8%
Long-Acting Rate
Brand vs Generic
Brand: 862 claims · $745K
Generic: 3,226 claims · $159K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 103 | $149K |
| Dulaglutide | 101 | $110K |
| Dapagliflozin Propanediol | 35 | $44K |
| Buprenorphine Hcl/Naloxone Hcl | 107 | $34K |
| Semaglutide | 29 | $30K |
| Apixaban | 24 | $27K |
| Fluticasone Propion/Salmeterol | 34 | $18K |
| Sitagliptin Phosphate | 15 | $18K |
| Rivaroxaban | 17 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 32 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $14K |
| Linaclotide | 16 | $13K |
| Varenicline Tartrate | 32 | $13K |
| Insulin Aspart | 15 | $12K |
| Fluticasone Propionate | 35 | $12K |
Prescribing Profile
Patient Profile
67
Avg Age
56%
Female
1.44
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data